NAGE logo

NAGE

NA

$6.88
+$0.17(+2.53%)
27
Overall
45
Value
10
Tech
--
Quality
Market Cap
$583.38M
Volume
844.91K
52W Range
$5.16 - $14.69
Target Price
$15.25

Company Overview

Mkt Cap$583.38MPrice$6.88
Volume844.91KChange+2.53%
P/E Ratio68.2Open$6.73
Revenue$99.6MPrev Close$6.71
Net Income$8.6M52W Range$5.16 - $14.69
Div YieldN/ATarget$15.25
Overall27Value45
Quality--Technical10

No chart data available

About NA

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Latest News

Roth MKM Reaffirms Their Buy Rating on Niagen Bioscience (NAGE)

In a report released today, Sean McGowan from Roth MKM maintained a Buy rating on Niagen Bioscience, with a price target of $23.00. According to Ti...

TipRanks Auto-Generated Intelligence Newsdesk6 days ago

Niagen Bioscience Reports 33% Q3 Sales Increase

TipRanks Auto-Generated Newsdesk19 days ago
ABCD
1SymbolPriceChangeVol
2NAGE$6.88+2.5%844.91K
3
4
5
6

Get NA Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.